Core Diagnostics employs advanced diagnostic technologies to enhance clinical decision-making and improve patient outcomes. The laboratory utilizes Quantitative Real Time PCR (Polymerase Chain Reaction) to rapidly analyze patient samples, allowing for precise detection of pathogens and identification of antibiotic resistance markers. This technology is integral across various testing services, including respiratory, urinary, gastrointestinal, women's health, sexual health, and wound care. By providing accurate and timely results, often within 24-48 hours, Core Diagnostics enables healthcare providers to initiate safe and effective treatments more swiftly, thereby optimizing patient care.

The company emphasizes a patient-centered approach, ensuring that every sample is meticulously handled from collection to delivery. Core Diagnostics operates as a full-service, in-house laboratory, which allows for a high level of accountability and attention to detail in their testing processes. Their commitment to accuracy is underscored by their goal of empowering healthcare providers with reliable data, ultimately leading to better clinical decisions and improved health outcomes for patients. Additionally, Core Diagnostics offers lab-to-lab services, enabling other CLIA-certified laboratories to incorporate PCR testing into their offerings without incurring additional operational costs.

United States

Core Diagnostics is a California licensed CLIA certifiedlaboratory offering biomarker analysis and translational research support for studies ranging from early discovery to analyses of Phase III clinical trial samples.

Core Diagnostics

Company Details